Holen Sie sich die Stockscreener-App
532.02
1.81%
9.45
Handel nachbörslich:
533.99
1.97
+0.37%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$522.57
Offen:
$524.32
24-Stunden-Volumen:
1.45M
Relative Volume:
0.91
Marktkapitalisierung:
$203.50B
Einnahmen:
$42.37B
Nettoeinkommen (Verlust:
$6.14B
KGV:
33.36
EPS:
15.95
Netto-Cashflow:
$7.78B
1W Leistung:
+1.13%
1M Leistung:
-0.45%
6M Leistung:
-0.67%
1J Leistung:
+0.61%
1-Tages-Spanne:
$522.74
$536.79
1-Wochen-Bereich:
$515.77
$536.79
52-Wochen-Spanne:
$493.30
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
532.02 | 203.50B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
234.84 | 169.62B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
135.69 | 38.75B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.39 | 35.83B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
415.53 | 34.03B | 3.84B | 866.24M | 792.60M | 10.37 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Beyond Market Price: Uncovering Thermo Fisher Scientific Inc's Intrinsic Value - Yahoo Finance
Central Pacific Bank Trust Division Has $1.85 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
United States Chromatography Resin Market Competition, Forecast and Opportunities, 2029F Featuring Key Players, GE Healthcare, Merck, Thermo Fisher Scientific, Pall, and Purolite - GlobeNewswire
United States Chromatography Resin Market Competition, Forecast and Opportunities, 2029F Featuring Key Players, GE Healthcare, Merck, Thermo Fisher Scientific, Pall, and Purolite - GlobeNewswire Inc.
Thermo Fisher Scientific to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 - BioSpace
Thermo Fisher CEO Marc Casper to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Microcarrier Market Size, Potential Scope 2031 By Key Players- Thermo Fisher Scientific Inc., Merck KGaA - openPR
Hemoglobin A1c (HbA1c) Testing Market Projected to Reach $1.83 Billion by 2024, Growth Fueled by Rising Prevalence of Diabetes - GlobeNewswire Inc.
Trace Metal Analysis Market Is Booming Worldwide 2024-2031 | - openPR
Helicobacter Pylori Diagnostic Market Top PlayersThermo - openPR
Whole Exome Sequencing Market Key Players AnalysisThermo - openPR
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025 - BioSpace
Confluence Investment Management LLC Cuts Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific (TMO): The Best Nanotechnology Stock to Buy According to Hedge Funds? - Insider Monkey
Bioconjugation Market Global Forecast to 2029 with Danaher, - GlobeNewswire
Is Thermo Fisher Scientific (NYSE:TMO) the Best Low Volatility Stock to Buy Right Now? - Insider Monkey
Thermo Fisher Scientific Inc. (NYSE:TMO) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Metagenomics Market Is Booming Worldwide 2024-2031 | Illumina, - openPR
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
Why Is Thermo Fisher Scientific (TMO) the Top CRISPR Stock to Invest In? - Insider Monkey
Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet? - Simply Wall St
Exosome Research Market Top Companies StudyThermo Fisher - openPR
Is Thermo Fisher Scientific Inc. (TMO) the Best Stock for 10 Years? - Insider Monkey
Long-Term Stock Portfolio: Best Stocks for 10 Years - Insider Monkey
Jim Cramer on Thermo Fisher Scientific Inc. (TMO): ‘I Think Things Will Gradually Improve For Thermo Fisher With Business Picking Up In 2025 and 2026’ - Insider Monkey
Thermo Fisher Scientific Increases Quarterly Dividend payable on April 16, 2020 - BioSpace
8 Stocks on Jim Cramer’s Radar - Insider Monkey
Thermo Fisher Scientific Inc. stock outperforms market despite losses on the day - MarketWatch
Crispr Market Detailed In New Research Report 2024 | Thermo - openPR
Proteomics Market Key Players AnalysisThermo Fisher - openPR
Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch
RPMI Media Market Key Players AnalysisMerck KGaA, Thermo - openPR
Thermo Fisher Scientific Further Expands Global Footprint for Drug Product Development and Commercial Manufacturing - Marketscreener.com
Thermo Fisher Scientific Inc: An Exploration into Its Intrinsic Value - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Tuesday, still underperforms market - MarketWatch
Legionella Testing Market Key Players AnalysisThermo Fisher - openPR
Predictive Biomarkers Market Top Companies StudyThermo - openPR
Scotiabank Initiates Coverage of Thermo Fisher Scientific (TMO) with Sector Perform Recommendation - MSN
Thermo Fisher Scientific Inc. stock rises Monday, still underperforms market - MarketWatch
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Pony AI, Thermo Fisher initiated: Wall Street's top analyst calls - Yahoo Finance
Thermo Fisher Scientific (NYSE:TMO) Earns Sector Perform Rating from Analysts at Scotiabank - MarketBeat
Immuno-Oncology Assays Market Future Business Opportunities - openPR
Recombinant Human (EGF) Market Is Booming Worldwide 2024-2031 | - openPR
Jim Cramer Reports That Thermo Fisher Scientific Inc. (TMO)’s China Sales Were Flat Year-Over-Year In The Nine Months Ending In September - Insider Monkey
M&T Bank Corp Has $70.11 Million Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Primary Cells Market Key Players AnalysisThermo Fisher - openPR
Allergy Diagnostic Market New Product Development & Latest Trends | Thermo Fisher Scientific, PerkinElmer, Danaher - openPR
Gamma Ray Spectroscopy Market Is Booming Worldwide 2024-2031 | - openPR
mRNA Extraction and Purification Market Top PlayersQiagen, - openPR
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):